Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2025-12-24 @ 11:41 PM
NCT ID:
NCT06457451
Eligibility Criteria:
Inclusion Criteria:
* Subject aged 18 or over
* Suffering from cystic fibrosis
* Treated with Elexacaftor-Tezacaftor-Ivacaftor for at least 6 months
* Affiliated to a social security scheme
* with a signed Informed Consent form.
Exclusion Criteria:
* Pregnant and breast-feeding women
* Subject under legal protection, guardianship or curatorship
* Subject whose physical activity is not medically authorised or whose physical and motor capacities do not allow them to take part in physical activity.
* Subject who is unable to comply with the requirements of the DIAPASOM program
* Difficulty in understanding the self-questionnaires
* Wearing a pacemaker or metal prosthesis
* Fluid retention
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06457451
Study Brief:
Protocol Section:
NCT06457451